Early benefit assessment increases transparency for study data

In the British Medical Journal, IQWiG researchers award good grades to the German Act on the Reform of the Market for Medicinal Products. The act has revealed a large amount of information on clinical studies. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *